Dynamic purchasing system for ranibizumab supply
Original notice title
Dynamisch aankoopsysteem voor de levering van ranibizumab
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
65 / 100
Risk factors
Crucial details (deadlines, specific requirements, lot values) are missing from the structured data and XML notice, inc...
Submissions must be in Dutch only, which may limit non-Dutch speaking bidders.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 10.3M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 3 lots
- Supply of ranibizumab (ophthalmologicals) for continuous and urgent needs
- Dynamic Purchasing System (DPS) allowing repeated procurement over time
Show full summary
This notice establishes a Dynamic Purchasing System (DPS) for the supply of ranibizumab (ophthalmologicals) by HospiLim VZW in Belgium. The estimated total value is EUR 10,340,000. The DPS is divided into four lots, though only the first lot (Ranibizumab) has full details. The procedure is restricted, with electronic submission required, and the official language is Dutch. No submission deadline is provided in the structured data; the DPS is open until 10 June 2028. Award criteria vary by lot (cost for lot 1, quality for others). Selection criteria are referenced to procurement documents, which were not analyzed.
Risks
Crucial details (deadlines, specific requirements, lot values) are missing from the structured data and XML notice, inc...
Submissions must be in Dutch only, which may limit non-Dutch speaking bidders.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Electronic submission required
- Submission in Dutch (NLD)
- Tenders must be submitted via the e-Procurement platform
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Hospilim VZW
Location
Diepenbeek, BEL
Website
Identifier
0833506251_1137
Lots (3)
LOT-0001
2024-HospiLim-108 - 1 - Ranibizumab
Supply of ranibizumab via DPS. Place of performance: BE224 (Limburg). Award based on total net cost.
Location
Category
Selection criteria
Award details
Show original TED data
Original TED description
Teneinde te kunnen beantwoorden aan de continue en desgevallend dringende behoefte tot aanschaf van ranibizumab, wenst HospiLim over te gaan tot het inrichten van een dynamisch aankoopsysteem. Dit aankoopsysteem kan vervolgens door HospiLim aangewend worden om de geselecteerde ondernemers uit te nodigen een offerte in te dienen voor één of meerdere opdrachten betreffende de levering van ranibizumab.
Lot 2
Lot 2
Lot 2: Place of performance BE223 (Oost-Vlaanderen). Award criteria: quality. No further details provided.
Category
Lot 3
Lot 3
Lot 3: Place of performance BE225 (West-Vlaanderen). Award criteria: quality. No further details provided.
Category
Procurement Details
- Publication date
- 01 Jul 2024
- Notice type
- Contract notice — standard
- Languages
- Dutch
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 389990-2024
- Source notice ID
- e80d0c2d-fe8b-4838-a1fa-4b23efb4df7b
Documents (2)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antithrombotic agents – Dostawa produktów leczniczych do leczenia zaburzeń w funkcjonowaniu przewodu pokarmowego, środków antybakteryjnych do użytku ogólnoustrojowego (...) w podziale na 21 części.
Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Romania – Pharmaceutical products – Acord cadru centralizat pentru 24 luni de furnizare OTC-uri IV/2026
Romania – Pharmaceutical products – ACHIZITIE MEDICAMENTE
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
65 / 100
Risk factors
Crucial details (deadlines, specific requirements, lot values) are missing from the structured data and XML notice, inc...
Submissions must be in Dutch only, which may limit non-Dutch speaking bidders.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications